Mutant NPM1: Nuclear export and the mechanism of leukemogenesis

被引：5
|
作者：
Falini, Brunangelo [1 ,2 ,3 ,6 ]
Martelli, Maria Paola [1 ,2 ,3 ]
Brunetti, Lorenzo [4 ,5 ]
机构：
[1] Univ Perugia, Inst Hematol, Perugia, Italy
[2] Univ Perugia, Ctr Hematooncol Res CREO, Perugia, Italy
[3] Santa Maria Misericordia Hosp, Perugia, Italy
[4] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy
[5] Osped Riuniti Marche, Dept Hematol, Ancona, Italy
[6] Univ Perugia, CREO, Perugia, Italy
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期
基金：
欧盟地平线“2020”;
关键词：
ACUTE MYELOID-LEUKEMIA; CYTOPLASMIC NUCLEOPHOSMIN;
D O I：
10.1002/ajh.26862
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：550 / 552
页数：3
相关论文
共 50 条
  • [41] Interaction of CacyBP/SIP with NPM1 and its influence on NPM1 localization and function in oxidative stress
    Rosinska, Sara
    Filipek, Anna
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (11) : 8826 - 8838
  • [42] Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
    Kuhn, Michael W. M.
    Song, Evelyn
    Feng, Zhaohui
    Sinha, Amit
    Chen, Chun-Wei
    Deshpande, Aniruddha J.
    Cusan, Monica
    Farnoud, Noushin
    Mupo, Annalisa
    Grove, Carolyn
    Koche, Richard
    Bradner, James E.
    de Stanchina, Elisa
    Vassiliou, George S.
    Hoshii, Takayuki
    Armstrong, Scott A.
    CANCER DISCOVERY, 2016, 6 (10) : 1166 - 1181
  • [43] Pitfalls in the molecular follow up of NPM1 mutant acute myeloid leukemia.
    Bacher, Ulrike
    Porret, Naomi
    Joncourt, Raphael
    Sanz, Javier
    Aliu, Nijas
    Wiedemann, Gertrud
    Jeker, Barbara
    Banz, Yara
    Pabst, Thomas
    HAEMATOLOGICA, 2018, 103 (10) : E486 - E488
  • [44] Combined Use of Ziftomenib and Selinexor Is Effective in NPM1 Mutant Acute Myeloid Leukemia
    Dhiman, Sandhya
    Uddin, Md. Hafiz
    Dhillon, Vikram
    Aguilar, Jeff Justin
    Aboukameel, Amro
    Khan, Husain
    Bannoura, Sahar
    Yang, Jay
    Dyson, Gregory
    Buck, Steven
    Azmi, Asfar
    Polin, Lisa
    Burrows, Francis
    Kessler, Linda
    Maciejewski, Jaroslaw
    Balasubramanian, Suresh Kumar
    BLOOD, 2024, 144 : 2768 - 2769
  • [45] TARGETING CHROMATIN REGULATORS INHIBITS LEUKEMOGENIC GENE EXPRESSION IN NPM1 MUTANT LEUKEMIA
    Kuehn, M. W.
    Song, E.
    Feng, Z.
    Sinha, A.
    Chen, C. W.
    Deshpande, A. J.
    Cusan, M.
    Farnoud, N. Rahnamay
    Koche, R.
    Bradner, J. E.
    de Stanchina, E.
    Vassiliou, G. S.
    Hoshii, T.
    Armstrong, S. A.
    HAEMATOLOGICA, 2016, 101 : 323 - 323
  • [46] Mutant NPM1 marginally impacts ribosome footprint in acute myeloid leukemia cells
    Brunetti, Lorenzo
    Pianigiani, Giulia
    Gundry, Michael C.
    Goodell, Margaret A.
    Falini, Brunangelo
    EJHAEM, 2024, 5 (05): : 1028 - 1032
  • [47] A new NPM1 gene mutation
    Jose Illana, Francisco
    Manrique, Antonio
    Coria-Ramirez, Erika
    Anguita, Eduardo
    LEUKEMIA & LYMPHOMA, 2015, 56 (12) : 3449 - 3451
  • [48] NPM1 IS REQUIRED FOR NORMAL HEMATOPOIESIS
    Ang, C. H.
    Xu, Z.
    Alexander, W.
    Glaser, S.
    HAEMATOLOGICA, 2016, 101 : 118 - 118
  • [49] THE ABSENT/LOW EXPRESSION OF CD34 IN NPM1-MUTATED AML IS NOT RELATED TO THE CYTOPLASMIC DISLOCATION OF NPM1 MUTANT
    Pianigiani, G.
    Rocchio, F.
    Peruzzi, S.
    Andresen, V.
    Martelli, M. P.
    Brunetti, L.
    Falini, B.
    HAEMATOLOGICA, 2022, 107 : 68 - 69
  • [50] NPM1 Biology in Myeloid Neoplasia
    Sanjay S. Patel
    Michael J. Kluk
    Olga K. Weinberg
    Current Hematologic Malignancy Reports, 2020, 15 : 350 - 359
12345